cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway

Kidney International

Volumn 57, Issue 4, 2000, Pages 1460-1471

  Yamaguchi, Tamio ^a   Pelling, Jill C ^a   Ramaswamy, Nadja T ^a   Eppler, Jason W ^a   Wallace, Darren P ^a   Nagao, Shizuko ^a   Rome, Lorraine A ^a   Sullivan, Lawrence P ^a   Grantham, Jared J ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Adenylyl cyclase; ADPKD; Fluid secretion; Kidney; Mitogen; PKD

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; ARGIPRESSIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DESMOPRESSIN; FORSKOLIN; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROSTAGLANDIN E2; PROTEIN TYROSINE KINASE; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

CELL PROLIFERATION; CHLORIDE TRANSPORT; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CORTEX; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 0034126459     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00991.x     Document Type: Conference Paper

References (41)

1. 1. GABOW PA: Definition and natural history of autosomal dominant polycystic kidney disease, in Polycystic Kidney Disease, edited by Watson ML, Torres VE, Oxford, Oxford University Press, 1996, pp 333-355
2. 2. GRANTHAM JJ: The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: Recent advances. Am J Kidney Dis 28:788-803, 1996
3. 3. GRANTHAM JJ: Polycystic kidney disease: Neoplasia in disguise. Am J Kidney Dis 15:110-116, 1990
4. 4. MARTINEZ JR, GRANTHAM JJ: Polycystic kidney disease: Etiology, pathogenesis and treatment. Dis Mon 41:693-768, 1995
5. 5. SULLIVAN LP, WALLACE DP, GRANTHAM JJ: Chloride and fluid secretion in polycystic kidney disease. J Am Soc Nephrol 9:903-916, 1998
6. 6. SULLIVAN LP, WALLACE DP, GRANTHAM JJ: Epithelial transport in polycystic kidney disease. Physiol Rev 78:1165-1191, 1998
7. 7. HANAOKA K, DEVUYST O, SCHWIEBERT EM, WILSON PD, GUGGINO WB: A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol 270:C389-C399, 1996
8. 8. BRILL SR, ROSS KE, DAVIDOW CJ, YE M, GRANTHAM JJ, CAPLAN MJ: Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells. Proc Natl Acad Sci USA 93:10206-10211, 1996
9. 9. DAVIDOW CJ, MASER RL, ROME LA, CALVET JP, GRANTHAM JJ: The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelia in vitro. Kidney Int 50:208-218, 1996
10. 10. GRANTHAM JJ: Renal cell proliferation and the two faces of cyclic adenosine monophosphate. J Lab Clin Med 130:459-460, 1997
11. 11. WALLACE DP, GRANTHAM JJ, SULLIVAN LP: Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int 50:1327-1336, 1996
12. 12. MANGOO-KARIM R, UCHIC M, LECHENE C, GRANTHAM JJ: Renal epithelial cyst formation and enlargement in vitro: Dependence on cAMP. Proc Natl Acad Sci USA 86:6007-6011, 1989
13. 13. YAMAGUCHI T, NAGAO S, KASAHARA M, TAKAHASHI H, GRANTHAM JJ: Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 30:703-709, 1997
14. 14. MATOUSOVIC K, TSUBOI Y, WALKER H, GRANDE JP, DOUSA TP: Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid. J Lab Clin Med 130:487-495, 1997
15. 15. NEUFELD TK, DOUGLASS D, GRANT M, YE M, SILVA F, NADASDY T, GRANTHAM JJ: In vitro formation and expansion of cysts derived from human renal cortex epithelial cells. Kidney Int 41:1222-1236, 1992
16. 16. MANGOO-KARIM R, YE M, WALLACE DP, GRANTHAM JJ, SULLIVAN LP: Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells. Am J Physiol 269:F381-F388, 1995
17. 17. GRANTHAM. JJ, YE M, GATTONE VH, SULLIVAN LP: In vitro secretion by epithelium from polycystic kidneys. J Clin Invest 95:195-202, 1995
18. 18. RANKIN CA, ZIEMER DM, MASER RL, FOO I, CALVET JP: Growth characteristics of cells cultured from two murine models of polycystic kidney disease. In Vitro Cell Dev Biol 32:100-106, 1996
19. 19. RAMASWAMY NT, RONAI Z, PELLING JC: Rapid activation of JNK1 in UV-B irradiated epidermal keratinocytes. Oncogene 16:1501-1505, 1998
20. 20. WU J, DENT P, JELINEK T, WOLFMAN A, WEBER MJ, SIURGILL TW: Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065-1069, 1993
21. 21. COOK SJ, MCCORMICK F: Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069-1072, 1993
22. 22. MATOUSOVIC K, GRANDE JP, CHINI CCS, CHINI EN, DOUSA TP: Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. J Clin Invest 96:401-410, 1995
23. 23. LI X, ZARINETCHI F, SCHRIER RW, NEMENOFF RA: Inhibition of MAP kinase by prostaglandin E2 and forskolin in rat renal mesangial cells. Am J Physiol 269:C986-C991, 1995
24. 24. HANEDA M, ARAKI S, SUGIMOTO T, TOGAWA M, KOYA D, KIKKAWA R: Differential inhibition of mesangial MAP kinase cascade by cyclic nucleotides. Kidney Int 50:384-391, 1996
25. 25. WILSON PD, DU J, NORMAN JT: Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur J Cell Biol 61:131-138, 1993
26. 26. MURCIA NS, SWEENEY WE JR, AVNER ED: New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 55:1187-1197, 1999
27. 27. YAMADA T, TERADA Y, HOMMA MK, NONOGUCHI H, SASAKI S, TASUHITO Y, TOMITA K, MARUMO F: AVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells. Kidney Int 48:745-752, 1995
28. 28. HEASLEY HE, SENKFOR SI, WINITZ S, STRASHEIM A, TEITELBAUM I, BERL T: Hormonal regulation of MAP kinase in cultured rat inner medullary collecting tubule cells. Am J Physiol 267:F366-F373, 1994
29. 29. KAWASAKI H, SPRINGETT GM, MOCHIZUKI N, TOKI S, NAKAYA M, MATUSDA M, HOUSMAN DE, GRAYBIEL AM: A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279, 1998
30. 30. DEROOIJ J, ZWARTKRUIS FJT, VERHEIJEN MHG, COOL RH, NIJMAN SSMB, WITTINGHOFER A, BOS JL: Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474-477, 1998
31. 31. WITHERS DJ: Signaling pathways involved in the mitogenic effects of cAMP. Clin Sci 92:445-451, 1997
32. 32. DEPOORTERE F, VAN KEYMEULEN A, LUKAS J, COSTAGLIOLA S, BARTKOVA J, DUMONT JE, BARTEK J, ROGER PP, DREMIER S: A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. J Cell Biol 140:1427-1439, 1998
33. 33. LUKAS J, BARTKOVA J, BARTEK J: Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol 16:6917-6925, 1996
34. 34. ROESSLER WJ, VANDENBARK GR, HANSON RW: Cyclic AMP and the induction of eukaryotic gene transcription. J Biol Chem 263:9063-9066, 1988
35. 35. ERHARDT P, TROPPMAIR J, RAPP UR, COOPER GM: Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol 15:5524-5530, 1995
36. 36. VOSSLER MR, YAO H, YORK RD, PAN M-G, RIM CS, STORK PJS: cAMP activates MAP kinase and Elk-1 through a B-Raf-and Rap1-dependent pathway. Cell 89:73-82, 1997
37. 37. AMERICAN PKD1 CONSORTIUM: Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. Hum Mol Genet 4:575-582, 1995
38. 38. HUGHES J, WARD CJ, PERAL B, ASPINWALL R, CLARK K, SAN MILLAN JL, GAMBLE V, HARRIS PC: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10:151-160, 1995
39. 39. INTERNATIONAL POLYCYSTIC KIDNEY DISEASE CONSORTIUM: Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81:289-298, 1995
40. 40. MOCHIZUKI T, WU G, HAYASHI T, XENOPHONTOS SL, VELDHUISEN B, SARIS JJ, REYNOLDS DM, CAI Y, GABOW PA, PIERIDES A, KIMBERLING WJ, BREUNING MH, DELTAS CC, PETERS DJ, SOMLO S: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-1342, 1996
41. 41. GRANTHAM JJ, SCHREINER GF, ROME L, GRENZ L, JOLY A: Evidence for inflammatory and secretagogue lipids in cyst fluids from patients with autosomal dominant polycystic kidney disease. Proc Assoc Am Phys 109:397-408, 1997